Novatek Microelectronics Corp.

TWSE:3034 Voorraadrapport

Marktkapitalisatie: NT$299.7b

Novatek Microelectronics Toekomstige groei

Future criteriumcontroles 2/6

Novatek Microelectronics is forecast to grow earnings and revenue by 7.7% and 7.8% per annum respectively. EPS is expected to grow by 8.1% per annum. Return on equity is forecast to be 32.4% in 3 years.

Belangrijke informatie

7.7%

Groei van de winst

8.1%

Groei van de winst per aandeel

Semiconductor winstgroei20.7%
Inkomstengroei7.8%
Toekomstig rendement op eigen vermogen32.4%
Dekking van analisten

Good

Laatst bijgewerkt03 Nov 2024

Recente toekomstige groei-updates

Recent updates

Here's What Analysts Are Forecasting For Novatek Microelectronics Corp. (TWSE:3034) After Its Third-Quarter Results

Nov 04
Here's What Analysts Are Forecasting For Novatek Microelectronics Corp. (TWSE:3034) After Its Third-Quarter Results

Why Novatek Microelectronics Corp. (TWSE:3034) Could Be Worth Watching

Oct 16
Why Novatek Microelectronics Corp. (TWSE:3034) Could Be Worth Watching

Novatek Microelectronics (TWSE:3034) Looks To Prolong Its Impressive Returns

Oct 01
Novatek Microelectronics (TWSE:3034) Looks To Prolong Its Impressive Returns

Estimating The Fair Value Of Novatek Microelectronics Corp. (TWSE:3034)

Sep 16
Estimating The Fair Value Of Novatek Microelectronics Corp. (TWSE:3034)

Insufficient Growth At Novatek Microelectronics Corp. (TWSE:3034) Hampers Share Price

Aug 16
Insufficient Growth At Novatek Microelectronics Corp. (TWSE:3034) Hampers Share Price

Novatek Microelectronics Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Jul 31
Novatek Microelectronics Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Novatek Microelectronics (TWSE:3034) Is Reducing Its Dividend To NT$32.00

Jun 23
Novatek Microelectronics (TWSE:3034) Is Reducing Its Dividend To NT$32.00

Investors Shouldn't Overlook The Favourable Returns On Capital At Novatek Microelectronics (TWSE:3034)

Jun 20
Investors Shouldn't Overlook The Favourable Returns On Capital At Novatek Microelectronics (TWSE:3034)

Novatek Microelectronics Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Apr 30
Novatek Microelectronics Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

At NT$574, Is Novatek Microelectronics Corp. (TWSE:3034) Worth Looking At Closely?

Apr 23
At NT$574, Is Novatek Microelectronics Corp. (TWSE:3034) Worth Looking At Closely?

Novatek Microelectronics Corp.'s (TWSE:3034) Shares Lagging The Market But So Is The Business

Mar 23
Novatek Microelectronics Corp.'s (TWSE:3034) Shares Lagging The Market But So Is The Business

Novatek Microelectronics (TWSE:3034) Is Achieving High Returns On Its Capital

Feb 29
Novatek Microelectronics (TWSE:3034) Is Achieving High Returns On Its Capital

Here's Why I Think Novatek Microelectronics (TPE:3034) Might Deserve Your Attention Today

Apr 25
Here's Why I Think Novatek Microelectronics (TPE:3034) Might Deserve Your Attention Today

Is Novatek Microelectronics Corp. (TPE:3034) A Good Fit For Your Dividend Portfolio?

Apr 11
Is Novatek Microelectronics Corp. (TPE:3034) A Good Fit For Your Dividend Portfolio?

An Intrinsic Calculation For Novatek Microelectronics Corp. (TPE:3034) Suggests It's 45% Undervalued

Mar 15
An Intrinsic Calculation For Novatek Microelectronics Corp. (TPE:3034) Suggests It's 45% Undervalued

What Type Of Shareholders Own The Most Number of Novatek Microelectronics Corp. (TPE:3034) Shares?

Mar 02
What Type Of Shareholders Own The Most Number of Novatek Microelectronics Corp. (TPE:3034) Shares?

Winst- en omzetgroeiprognoses

TWSE:3034 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (TWD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2026124,39424,75822,75424,36311
12/31/2025114,79522,76521,28722,90519
12/31/2024105,87420,97017,35121,91019
9/30/2024104,67920,86917,42318,296N/A
6/30/2024105,74321,97625,12725,859N/A
3/31/2024110,81123,45926,09626,832N/A
12/31/2023110,42923,31828,81829,981N/A
9/30/2023105,69522,03228,45429,870N/A
6/30/202396,32919,97223,97225,221N/A
3/31/202397,49121,58620,02421,272N/A
12/31/2022109,95727,97021,53222,691N/A
9/30/2022124,07934,86032,73033,824N/A
6/30/2022142,86142,82639,46840,724N/A
3/31/2022145,51144,12543,97045,672N/A
12/31/2021135,36638,86640,33741,721N/A
9/30/2021121,27631,57727,27929,787N/A
6/30/2021104,93222,71119,88723,714N/A
3/31/202189,43115,48115,68219,274N/A
12/31/202079,95611,81711,74215,380N/A
9/30/202074,0289,9754,9287,439N/A
6/30/202068,6238,6016,3497,628N/A
3/31/202066,3178,1715,7297,352N/A
12/31/201964,3727,9275,2447,147N/A
9/30/201963,1938,1786,7569,011N/A
6/30/201962,3547,9864,7226,844N/A
3/31/201959,3147,4425,0156,532N/A
12/31/201854,8346,3916,7518,011N/A
9/30/201851,4385,6537,1167,706N/A
6/30/201848,0805,368N/A8,676N/A
3/31/201846,6215,012N/A7,067N/A
12/31/201747,0745,024N/A4,382N/A
9/30/201746,3424,965N/A5,073N/A
6/30/201745,9654,638N/A4,652N/A
3/31/201745,5994,712N/A5,254N/A
12/31/201645,6515,004N/A7,049N/A
9/30/201647,0635,264N/A8,204N/A
6/30/201648,1265,735N/A8,399N/A
3/31/201649,1425,921N/A7,941N/A
12/31/201550,8706,399N/A9,135N/A
9/30/201553,3476,970N/A8,381N/A
6/30/201555,5457,360N/A7,992N/A
3/31/201556,1727,642N/A6,972N/A
12/31/201454,0677,209N/A5,749N/A
9/30/201449,5686,313N/A4,697N/A
6/30/201444,8605,465N/A3,841N/A
3/31/201442,7054,951N/A4,838N/A
12/31/201341,4504,745N/A4,880N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 3034's forecast earnings growth (7.7% per year) is above the savings rate (1%).

Winst versus markt: 3034's earnings (7.7% per year) are forecast to grow slower than the TW market (19.1% per year).

Hoge groeiwinsten: 3034's earnings are forecast to grow, but not significantly.

Omzet versus markt: 3034's revenue (7.8% per year) is forecast to grow slower than the TW market (12.3% per year).

Hoge groei-inkomsten: 3034's revenue (7.8% per year) is forecast to grow slower than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: 3034's Return on Equity is forecast to be high in 3 years time (32.4%)


Ontdek groeibedrijven